Takeda delivers strong h1 fy2021 results; further growth momentum expected through fiscal year-end driven by 14 global brands

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tokyo:4502/nyse:tak) (“takeda”) today announced financial results for the first half of fiscal year 2021 (period ended september 30, 2021). based on the strong first half results, the company also confirmed its fiscal year 2021 management guidance. fiscal year 2021, ending in march 31, 2022, continues to be a year of growth with anticipated topline acceleration driven by the company's 14 global brands. in addition, the compan
TAK Ratings Summary
TAK Quant Ranking